GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » ArcticZymes Technologies ASA (FRA:B4V) » Definitions » Cash Receipts from Securities Related Activities

ArcticZymes Technologies ASA (FRA:B4V) Cash Receipts from Securities Related Activities


View and export this data going back to . Start your Free Trial

What is ArcticZymes Technologies ASA Cash Receipts from Securities Related Activities?

Cash Receipts from Securities Related Activities only applicable to companies reporting Cash Flow from Operations in direct method.


ArcticZymes Technologies ASA (FRA:B4V) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » ArcticZymes Technologies ASA (FRA:B4V) » Definitions » Cash Receipts from Securities Related Activities
Traded in Other Exchanges
Address
Sykehusveien 23, Tromso, NOR, N-9294
ArcticZymes Technologies ASA is a biotechnology company. The company is engaged in developing, producing, and marketing immune-modulating beta-glucans and novel recombinant enzymes. The company's products include Woulgan wound gel, Feed Ingredient (M-Glucan), Nutraceuticals (M-Gard), Recombinant enzymes, and others. The company reports in two operating segments that are Enzymes and Corporate. Geographically, it derives a majority of revenue from the USA.